MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova r&d expenses
Research and development expenses are spending on new products and technology.
MediciNova's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.00M, down 31.5% year over year. For fiscal 2025 it was $6.70M, down 1.5% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $10.87M in fiscal 2009.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.70M | -1.5% |
| FY2024 | Dec 31, 2024 | $6.80M | +28.3% |
| FY2023 | Dec 31, 2023 | $5.30M | -39.1% |
| FY2022 | Dec 31, 2022 | $8.70M | +7.4% |
| FY2021 | Dec 31, 2021 | $8.10M | +14.1% |
| FY2020 | Dec 31, 2020 | $7.10M | +24.6% |
| FY2019 | Dec 31, 2019 | $5.70M | +7.5% |
| FY2018 | Dec 31, 2018 | $5.30M | +35.9% |
| FY2017 | Dec 31, 2017 | $3.90M | +25.8% |
| FY2016 | Dec 31, 2016 | $3.10M | +14.8% |
| FY2015 | Dec 31, 2015 | $2.70M | -6.9% |
| FY2014 | Dec 31, 2014 | $2.90M | +7.4% |
| FY2013 | Dec 31, 2013 | $2.70M | -40.0% |
| FY2012 | Dec 31, 2012 | $4.50M | -42.2% |
| FY2011 | Dec 31, 2011 | $7.78M | -19.8% |
| FY2010 | Dec 31, 2010 | $9.71M | -10.7% |
| FY2009 | Dec 31, 2009 | $10.87M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $900.00K | -55.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.20M | -29.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.40M | -22.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.50M | -16.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.00M | +33.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.70M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.80M | +12.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.80M | +157.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.50M | -6.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.70M | +21.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.60M | -15.8% |
| Q3 FY2023 | Sep 30, 2023 | $700.00K | -70.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.60M | -36.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.40M | -30.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.90M | +11.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.40M | +20.0% |
| Q2 FY2022 | Jun 30, 2022 | $2.50M | +8.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.00M | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.70M | 0.0% |
| Q3 FY2021 | Sep 30, 2021 | $2.00M | -4.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.30M | +9.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.00M | +66.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.70M | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.10M | +90.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.10M | +50.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.20M | -20.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.70M | +1600.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.10M | -52.2% |
| Q2 FY2019 | Jun 30, 2019 | $1.40M | +7.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.50M | -6.3% |
| Q4 FY2018 | Dec 31, 2018 | $100.00K | -90.0% |
| Q3 FY2018 | Sep 30, 2018 | $2.30M | +91.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.30M | +62.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.60M | +100.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.00M | +150.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.20M | +50.0% |
| Q2 FY2017 | Jun 30, 2017 | $800.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $800.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $400.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $800.00K | – |
See a number that looks wrong?